Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Nuwellis, Inc. (NUWE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.6200+0.0241 (+4.04%)
At close: 04:00PM EDT
0.6200 0.00 (0.00%)
After hours: 06:27PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close0.5959
Open0.6352
Bid0.6200 x 900
Ask0.6415 x 900
Day's Range0.5905 - 0.6450
52 Week Range0.4700 - 2.4800
Volume85,582
Avg. Volume3,496,284
Market Cap6.533M
Beta (5Y Monthly)0.22
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for NUWE

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Nuwellis, Inc.
    Analyst Report: Becton, Dickinson And Co.Headquartered in Franklin Lakes, New Jersey, BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, life science researchers, clinical laboratories, industry, and the general public. Its operations consist of three worldwide business segments: BD Medical, BD Life Sciences, and BD Interventional.
    Rating
    Fair Value
    Economic Moat
    3 days agoArgus Research
View more
  • We're sorry we weren't able to find anything about this topic.

Advertisement
Advertisement